Phase 2
N=80
Clonidine Added Lidocaine in Intraocular Pressure and Hemodynamics Ocular in Sub-Tenon's and Peribulbar Anesthesia
Anesthesia
Bottom Line
View on ClinicalTrials.gov: NCT02733757 ↗Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Aug 2020
Primary outcome: Primary: Intraocular Pressure (IOP) — 18; 16; 19; 16 mmHg
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Clonidine (Drug)
- Age
- Adult, Older Adult · 30+ yrs
- Sex
- All
- Sponsor
- Federal University of Minas Gerais
- Primary completion
- Oct 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intraocular Pressure (IOP) |
18; 16; 19; 16 | — |
Summary
Regional anesthesia in orbit can reduce ocular blood flow, increase in intraocular pressure (IOP) or the pharmacological action of local anesthetics. This study was conduced to evaluate the effects of clonidine added to lidocaine in IOP, ocular perfusion pressure (PPO) and ocular pulse amplitude (OPA) in patients undergoing cataract surgery under sub-Tenon's and peribulbar anesthesia.
Eligibility Criteria
Inclusion Criteria
- Adults between 30 and 86 years old
- Both genders
- Physical status ASA (American Society of Anesthesiologists) I and II
- Cooperative patients undergoing cataract surgery by phacoemulsification
Exclusion Criteria
- Patients with communication difficulties
- Allergic to any medication protocol
- Chronic therapy with clonidine
- In use of antihypertensive medication
- Diabetes
- Glaucoma
- Previous surgery in the same eye
- Abnormalities in coagulation
Data sourced from ClinicalTrials.gov (NCT02733757). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.